Cargando…
Complete map of SARS-CoV-2 RBD mutations that escape the monoclonal antibody LY-CoV555 and its cocktail with LY-CoV016
Monoclonal antibodies and antibody cocktails are a promising therapeutic and prophylaxis for COVID-19. However, ongoing evolution of SARS-CoV-2 can render monoclonal antibodies ineffective. Here we completely map all mutations to the SARS-CoV-2 spike receptor binding domain (RBD) that escape binding...
Autores principales: | Starr, Tyler N., Greaney, Allison J., Dingens, Adam S., Bloom, Jesse D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7924270/ https://www.ncbi.nlm.nih.gov/pubmed/33655250 http://dx.doi.org/10.1101/2021.02.17.431683 |
Ejemplares similares
-
Complete map of SARS-CoV-2 RBD mutations that escape the monoclonal antibody LY-CoV555 and its cocktail with LY-CoV016
por: Starr, Tyler N., et al.
Publicado: (2021) -
SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19
por: Chen, Peter, et al.
Publicado: (2020) -
The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates
por: Jones, Bryan E., et al.
Publicado: (2021) -
LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants
por: Westendorf, Kathryn, et al.
Publicado: (2022) -
An antibody-escape calculator for mutations to the SARS-CoV-2 receptor-binding domain
por: Greaney, Allison J., et al.
Publicado: (2021)